II
IRMD icon

Inspire Investing’s iRadimed IRMD Stock Holding History

Inspire Investing’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$120K Buy
1,256
+148
+13% +$13.5K ﹤0.01% 1054
2026
Q1 		$107K Buy
+1,108
New +$111K 0.01% 906

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Inspire Investing's IRMD Position: Q2 2026 in Review

Inspire Investing increased its iRadimed (IRMD) stake by 13% in Q2 2026, buying an estimated $13.5K and bringing the position to 1,256 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Inspire Investing first reported a position in IRMD in Q1 2026 and has held it in 2 quarters since. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Inspire Investing held 1,256 shares of iRadimed worth $120K as of Q2 2026.
  • Inspire Investing bought 148 iRadimed shares in Q2 2026, an estimated $13.5K.
  • iRadimed made up ﹤0.01% of Inspire Investing's portfolio in Q2 2026, its #1054 holding.
  • Inspire Investing first reported a position in iRadimed in Q1 2026 and has held it in 2 quarters since.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Inspire Investing's 13F filing for Q2 2026, filed 12 Aug 2026.